Stein Steven H reported option exercise involving 19,749 shares of INCYTE CORP at $61.18 for $1.21M on Nov 6, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
CMO & Head of Late-Stage Dev.
CMO & Head of Late-Stage Dev.
Filed Nov 10, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$1,208,243.82Shares × reported price
Shares traded
19,749Common Stock
Price per share
$61.18Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
144,878Direct
Trade date
Nov 6, 2026Option exercise
Filed
Nov 10, 2026, 4:07 PM ET4-day reporting delay
Accession
0001673776-26-000022Code M · Transaction 396904
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 6, 2026Option exercise8,539$68.62$585,946.18Trade 396898
Nov 6, 2026Option exercise12,335$72.27$891,450.45Trade 396899
Nov 6, 2026Option exercise16,428$80.50$1,322,454Trade 396900
Nov 6, 2026Option exercise15,054$74.78$1,125,738.12Trade 396901
Nov 6, 2026Option exercise23,526$77.67$1,827,264.42Trade 396902
Nov 6, 2026Option exercise18,331$61.76$1,132,122.56Trade 396903
Nov 6, 2026Option exercise12,305$64.25$790,596.25Trade 396905
Nov 6, 2026Option exercise6,907$68.25$471,402.75Trade 396906
Nov 6, 2026Option exercise16,428$85.01$1,396,544.28Trade 396907
Nov 6, 2026Option exercise12,743$90.56$1,154,006.08Trade 396908
Nov 6, 2026Option exercise15,054$83.58$1,258,213.32Trade 396909
Nov 6, 2026Option exercise24,838$83.20$2,066,521.60Trade 396910
Nov 6, 2026Option exercise879$113.64$99,889.56Trade 396911
Nov 6, 2026Option exercise17,986$113.64$2,043,929.04Trade 396912
Nov 6, 2026Option exercise19,091$113.64$2,169,501.24Trade 396913
Nov 6, 2026Option exercise17,986$0.00$0Trade 396933
Nov 6, 2026Option exercise19,091$0.00$0Trade 396934
Nov 6, 2026Option exercise8,539$0.00$0Trade 396919
Nov 6, 2026Option exercise12,335$0.00$0Trade 396920
Nov 6, 2026Option exercise16,428$0.00$0Trade 396921
Nov 6, 2026Option exercise15,054$0.00$0Trade 396922
Nov 6, 2026Option exercise23,526$0.00$0Trade 396923
Nov 6, 2026Option exercise18,331$0.00$0Trade 396924
Nov 6, 2026Option exercise19,749$0.00$0Trade 396925
Nov 6, 2026Option exercise12,305$0.00$0Trade 396926
Nov 6, 2026Option exercise6,907$0.00$0Trade 396927
Nov 6, 2026Option exercise12,743$0.00$0Trade 396929
Nov 6, 2026Option exercise24,838$0.00$0Trade 396931
Nov 6, 2026Sell35,042$116.06−$4,067,086.65Trade 396914
Nov 6, 2026Sell22,336$117.15−$2,616,550.72Trade 396915
Nov 6, 2026Sell60,270$118.27−$7,128,307.68Trade 396916
Nov 6, 2026Sell73,969$119.12−$8,811,009.75Trade 396917
Nov 6, 2026Sell48,576$119.66−$5,812,793.61Trade 396918
Nov 6, 2026Option exercise879$0.00$0Trade 396932
35 transaction rows in this filing. Joint filers share the same rows.

INCY price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
INCY · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −6.9%1w ago −1.2%1d ago −3.2%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.56 to $116.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.64 to $117.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.64 to $118.635 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.64 to $119.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.65 to $119.79 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F6: This includes an aggregate of 29,338 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. F7: Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. F8: Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2019 and the remainder vesting monthly over three years. F9: Beginning January 17, 2020, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2020 and the remainder vesting monthly over three years. F10: Beginning January 19, 2022, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2022 and the remainder vesting monthly over three years. F11: Beginning July 2, 2022, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. F12: The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. F13: Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years. F14: The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. F15: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. F16: Beginning July 2, 2019, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. F17: Beginning January 15, 2021, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2021 and the remainder vesting monthly over three years. F18: Beginning July 2, 2021, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. F19: Beginning January 20, 2023, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2023 and the remainder vesting monthly over three years. F20: Beginning January 17, 2017, options become exercisable in full on January 17, 2021. F21: Beginning January 17, 2017, options become exercisable in 37 installments, with the first 25.00% vesting on July 15, 2017 and the remainder vesting monthly over three years.